Blog

Is There a Potential Benefit of Expressive Writing for Dermatology Patients?

Dr. Cohen is from the Division of Dermatology, University of California San Diego.

Dr. Cohen reports no conflicts of interest in relation to this post.


 

A diagnosis of a chronic and/or serious medical condition can be a traumatic experience. Patients may experience not only intrusive thoughts but also avoidance behaviors. The affected individuals can express these trauma-associated symptoms as depression, fatigue, and sleep disturbance.

Milbury et al (J Clin Oncol. 2014;32:663-670) included 277 patients who had been diagnosed with renal cell carcinoma in a study to evaluate if writing about their deepest thoughts and feelings regarding their cancer (expressive writing) offered a quality-of-life benefit compared to writing about neutral topics (neutral writing). They found that expressive writing not only reduced the patients’ cancer-related symptoms but also improved their physical functioning.

What’s the issue?

Many of the conditions that affect dermatology patients are chronic, serious, or both. For example, psoriasis is a chronic skin condition with the potential for serious associated rheumatologic or metabolic sequelae. In addition, skin malignancies (eg, basal cell carcinoma, squamous cell carcinoma, malignant melanoma) and cutaneous lymphoma (eg, mycosis fungoides) are conditions that require chronic surveillance and possibly may have serious consequences.

Expressive writing for dermatology patients might result in remarkable improvement in emotional and physical health. Perhaps dermatologists should recommend this intervention for their patients.

We want to know your views! Tell us what you think.

Recommended Reading

Vitamin D - Myths or Truths?
Psoriasis Collection
NIH at Forefront of New Clinical Trials Push, Director Says
Psoriasis Collection
Photodynamic Therapy Protocols Differ by Location
Psoriasis Collection
SDEF: Consider Potential Risks of Newly Approved Therapeutics
Psoriasis Collection
DANBIO: Anti-TNFs Do Not Up Overall Cancer Risk
Psoriasis Collection
Blog: Top 10 Stories of 2011
Psoriasis Collection
Malignancy Rates Remain Stable in Ustekinumab-Treated Patients
Psoriasis Collection
Don't Delay Psoriasis Treatment: The Skinny Podcast
Psoriasis Collection
AAD Unveils SPOT Program: The Skinny Podcast
Psoriasis Collection
Most Cancers Not Elevated in Vasculitis
Psoriasis Collection

Related Articles